Title: Stephen C. Alley, et al. Abstract DDT02-02: SGN-2FF: A novel small molecule inhibitor of fucosylation with preclinical antitumor activity through multiple immune mechanisms. Cancer Res 2017;77(13 Suppl).
40010-20-6
38440-79-8
56926-53-5
105851-17-0
141990-24-1
18961-68-7
1314069-51-6 | 4-chloro-N-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzenesulfonamide | AA01FNQC | MFCD22494720
89747-91-1 | Benazeprilate | AA01FNXX
1185303-12-1 | 4-(5-Methyl-furan-2-yl)-phenylamineoxalate | AA01FO1P
883529-71-3 | 5-Chloro-1-methyl-1H-indole-2-carbaldehyde | AA01FO4F | MFCD06800429
314763-96-7 | 3,5-Diphenyl-1H-pyrrole-2-carbohydrazide | AA01FO75
940511-63-7 | 5-[4-(1-Azepanylcarbonyl)anilino]-5-oxopentanoicacid | AA01FO9V
883523-41-9 | 6-(Cyclopropylmethoxy)[1 | AA01FOCT
288155-30-6 | 1,2-Bis(5-methyl-1H-pyrazol-3-yl)disulfane | AA01FOFQ
1048915-80-5 | (4-(5-chloro-2-methylphenyl)piperazinyl)((methylpropyl)amino)methane-1-thione | AA01FOIO
378756-30-0 | 2-chloro-3-[(2,4-dimethoxyphenyl)amino]-1,4-dihydronaphthalene-1,4-dione | AA01FOM6
